DIA Biosimilars 2013

Marken

Marken appoints general manager, China

Thursday, July 11, 2013 08:15 AM

Marken, a global clinical supply chain solutions provider, has appointed Joan Yan general manager for its Beijing office.  Yan will be responsible for the logistics operations in China and the new depot facility recently commissioned for the GMP storage and distribution of drug product and ancillary materials.

More... »

Cenduit: Now with Patient Reminders

Marken opens pharmaceutical depot in Beijing

Monday, March 11, 2013 11:07 AM

Marken, a global clinical supply chain solutions provider, has completed its new pharmaceutical depot in Beijing, China. The new facility which provides 850 square meters of GMP compliant space for temperature controlled storage as well as distribution of clinical trial supplies is co-located with the existing Marken Beijing branch office to provide a fully integrated and best in class service to clients.

More... »

CRF Health – eCOA Forum

Marken appoints two independent directors to board

Tuesday, March 5, 2013 04:10 PM

Marken, based in Research Triangle Park, N.C., has appointed two independent directors to its board, as a result of Marken's recent restructuring completed Dec. 21, 2012.  They are Timothy C. Tyson and Michael O'Donnell.

More... »

Marken opens two pharmaceutical depots in New York and Germany

Wednesday, September 5, 2012 11:02 AM

Marken, a global clinical supply chain solutions provider, has completed the first phase of its plan to create a global pharmaceutical depot network that will allow it to satisfy its client's needs for global distribution. Two new depots have been completed: one in Frankfurt, Germany, and one in Farmingdale, New York.

More... »

Marken expands four facilities

Tuesday, August 28, 2012 12:30 PM

Marken, based in Research Triangle Park, N.C., has opened four expanded branch facilities to meet continued growth.

More... »

Marken acquires European kit building operation from LabCorp Clinical Trials

Friday, May 4, 2012 03:44 PM

Marken, a global clinical supply chain solutions provider, has acquired the European kit building operation from Laboratory Corporation of America Holdings through its LabCorp Clinical Trials division.

More... »

Marken inaugurates new branches in India

Friday, March 16, 2012 11:08 AM

Marken continues their expansion of services in India by augmenting their existing Mumbai facility with four additional branches in New Delhi, Hyderabad, Pune and Bangalore.

More... »

Dr. Andrea Zobel joins Marken

Friday, January 13, 2012 12:07 PM

Marken has named Dr. Andrea Zobel new senior director of clinical trial distribution operations.

More... »

Roese joins Marken

Thursday, December 22, 2011 11:29 AM
Marken has named Steve Roese vice president of its global quality assurance organization, which will support Marken's continued investment in their expanding network of pharmaceutical service depots around the world.

More... »

Marken continues expansion with Buenos Aires facility

Tuesday, December 20, 2011 01:39 PM

Marken continues their expansion of services in Latin America, by augmenting their new purpose-built Buenos Aires facility.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs